| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/28/1994 | CA2147167A1 A new class of rptpases: their structural domains and ligands |
| 04/28/1994 | CA2147127A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | CA2147010A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
| 04/28/1994 | CA2146990A1 Chelating polymers |
| 04/28/1994 | CA2146988A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | CA2146929A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | CA2146765A1 New taxane derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 04/28/1994 | CA2146668A1 Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
| 04/27/1994 | EP0594311A1 Metastasis-inhibiting protein, and DNA encoding said protein |
| 04/27/1994 | EP0593901A2 Oligoribonucleotide- and ribozyme-analoguer with terminal 3',3'- and 5',5'-bonds respectively |
| 04/27/1994 | EP0593897A1 Stabilized solutions of alkylphosphocholine in glycerolalkylether |
| 04/27/1994 | EP0593755A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 04/27/1994 | EP0593754A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 04/27/1994 | EP0593663A1 Method and assay system for neurotrophin activity |
| 04/27/1994 | EP0593639A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same. |
| 04/27/1994 | EP0593601A1 Novel compositions based on taxane class derivatives |
| 04/27/1994 | EP0460034B1 Novel vitamin d analogues |
| 04/27/1994 | EP0460032B1 Novel vitamin d analogues |
| 04/27/1994 | EP0408546B1 Improvements relating to drug delivery systems |
| 04/27/1994 | EP0345294B1 Drugs containing platinum complexes |
| 04/27/1994 | CN1085901A Heterocyclic compounds |
| 04/27/1994 | CN1024345C Process for preparing cycloalkanylpyrrole |
| 04/26/1994 | US5306809 Acid-labile linker molecules |
| 04/26/1994 | US5306732 Administering vinigrol |
| 04/26/1994 | US5306727 Selectively cytotoxic in hypoxic cells |
| 04/26/1994 | US5306716 Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds |
| 04/26/1994 | US5306714 (S)-2,3-dihydropolyprenyl, monophosphate, and agents for inhibiting the metastasis of cancers |
| 04/26/1994 | CA1328948C Polypeptide compounds |
| 04/26/1994 | CA1328871C Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |
| 04/25/1994 | CA2109025A1 Imidazopyridines |
| 04/20/1994 | EP0592949A2 N-(aminocarbonyl)-piperidines/pepirazines as aggregation inhibiting agents |
| 04/20/1994 | EP0592835A2 BU-4803T Antibiotics |
| 04/20/1994 | EP0592634A1 Inhibitor of protein kinase c |
| 04/20/1994 | EP0592480A1 Papillomavirus l2 protein |
| 04/20/1994 | EP0592464A1 Chemotactic factor |
| 04/20/1994 | CN1085563A Novel peptides, the preparation and use thereof |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/20/1994 | CN1085553A Deoxy taxols |
| 04/20/1994 | CN1085552A Process for obtaining 10-deacetylbaccatin III |
| 04/19/1994 | US5304604 Treating diseases involving tissue degradation, promoting wound healing |
| 04/19/1994 | US5304562 17β-substituted Aza-androstane derivatives |
| 04/19/1994 | US5304373 Antitumor antibiotic |
| 04/19/1994 | CA1328661C Rolliniastatin 1 and means and methods for inhibiting cell growth therewith |
| 04/19/1994 | CA1328619C Toxicity profiles in chemotherapy |
| 04/19/1994 | CA1328605C Medicinal composition useful for the treatment of dermatological diseases |
| 04/14/1994 | WO1994008053A1 Oligonucleotides having a conserved g4 core sequence |
| 04/14/1994 | WO1994007881A1 Method of obtaining 10-deacetylbaccatine iii |
| 04/14/1994 | WO1994007879A1 Method of preparing taxane derivatives |
| 04/14/1994 | WO1994007878A1 Method of preparing taxane derivatives |
| 04/14/1994 | WO1994007877A1 Method of preparing taxane derivatives |
| 04/14/1994 | WO1994007875A1 Heterocyclic amines having colmodulin antagonist properties |
| 04/14/1994 | WO1994007862A1 Unsymmetrically substituted bis-naphthalimides |
| 04/14/1994 | WO1994007858A1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers |
| 04/14/1994 | WO1994007853A1 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
| 04/14/1994 | WO1994007852A1 Novel vitamin d analogues |
| 04/14/1994 | WO1994007851A1 Novel vitamin d analogues |
| 04/14/1994 | WO1994007530A1 Vaccines and antigenic conjugates |
| 04/14/1994 | WO1994007516A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | WO1994007497A1 USE OF DOPAMINE AGONISTS TO ACTIVATE η-INTERFERON PRODUCTION |
| 04/14/1994 | WO1994007479A2 Immunopotentiatory agents |
| 04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/14/1994 | WO1994007473A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGFαPE40ab |
| 04/14/1994 | WO1994004159A3 Treatment of cancer with azt and alkylating or intercalating agents |
| 04/14/1994 | CA2146572A1 Controlled-ph formulation for intravesicular instillation of tgfpe40 ab |
| 04/14/1994 | CA2146428A1 Use of dopamine agonists to activate -interferon production |
| 04/14/1994 | CA2146249A1 Process for preparing taxane derivatives |
| 04/14/1994 | CA2146163A1 Heterocyclic amines calmodulin antagonist properties |
| 04/14/1994 | CA2145867A1 Novel asymmetrically substituted bisnaphthalimides |
| 04/14/1994 | CA2145391A1 Vaccines and antigenic conjugates |
| 04/14/1994 | CA2144850A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | CA2136451A1 Novel vitamin d analogues |
| 04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
| 04/13/1994 | EP0591710A1 Injection solutions containing mesna |
| 04/13/1994 | EP0591408A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591355A1 Porphycene compounds for photodynamic therapy |
| 04/13/1994 | EP0591311A1 Controlled release systems and low dose androgens |
| 04/13/1994 | EP0591303A1 Methods and compositions for treating malaria and other diseases |
| 04/13/1994 | EP0538300B1 O-glycosylated ifn-alpha |
| 04/13/1994 | EP0446267B1 Hydroxamic acid based collagenase inhibitors |
| 04/13/1994 | EP0396616B1 Reduction of side effects of cancer therapy |
| 04/13/1994 | CN1085224A Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives |
| 04/13/1994 | CN1085211A Fluoride like vitamine D3 |
| 04/13/1994 | CN1024197C Process for preparing acylated derivs. of etoposide |
| 04/13/1994 | CA2108093A1 Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 04/12/1994 | US5302727 Multidrug resistance modifying dithianes |
| 04/12/1994 | US5302724 Antitumor compositions and methods of treatment |
| 04/12/1994 | US5302699 Antitumorigenic protein, method of preparing it and antitumorigenic composition containing the protein as active component |
| 04/12/1994 | US5302606 Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase |
| 04/12/1994 | US5302370 Form complexes with rhenium and technetium |
| 04/12/1994 | US5302369 Microspheres for radiation therapy |
| 04/12/1994 | CA1328402C Somatostatins |
| 04/07/1994 | DE4234380A1 Verwendung von Dopaminagonisten zur Aktivierung des gamma-Interferon-Produktion Use of dopamine agonists for the activation of the gamma-interferon production |
| 04/06/1994 | EP0591058A1 Ellipticine derivatives with antitumor activity |
| 04/06/1994 | EP0591057A1 Arylalkyl(thio)amides with melatonine receptor selectivity and process for their preparation |
| 04/06/1994 | EP0591040A1 Quaternary basic amides as tachykinines antagonists |
| 04/06/1994 | EP0590551A2 New therapeutic uses of phthalazinone-derivatives |
| 04/06/1994 | EP0590530A2 Fusion proteins for prodrug-activation |
| 04/06/1994 | EP0590520A1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments |
| 04/06/1994 | EP0590267A2 Deoxy taxols |